SLC2A1 and neoplasm: There were no significant differences in the expressions other five genes, COL1A2, PSAT1, SLC2A1, GCLM, and TTYH2 in terms depth of myometrial invasion, LVSI status, tumor histological grade, status of lymph node metastasis, and FIGO stage.